TrialBritish journal of cancer2018

Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial.

Tingyan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.